Quick Answer
Keros Therapeutics, Inc. reported Shares Outstanding of 19.54 million shares for fiscal year 2025.
Keros Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 19.54M | -51.8% |
| 2024 | 40.55M | +27.4% |
| 2023 | 31.84M | +15.6% |
| 2022 | 27.54M | +14.9% |
| 2021 | 23.97M | +3.4% |
| 2020 | 23.19M | +854.6% |
| 2019 | 2.43M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 40.63M | +3.5% | +0.0% |
| June 30, 2025 | 40.62M | +12.3% | +0.1% |
| March 31, 2025 | 40.56M | +12.5% | +0.0% |
| December 31, 2024 | 40.55M | +27.4% | +3.3% |
| September 30, 2024 | 39.26M | +32.3% | +8.5% |
| June 30, 2024 | 36.17M | +21.9% | +0.3% |
| March 31, 2024 | 36.07M | +22.1% | +13.3% |
| December 31, 2023 | 31.84M | +15.6% | +7.3% |
- Keros Therapeutics, Inc. showed a decrease of -51.8% in Shares Outstanding compared to the prior fiscal year.
- Over the 2019–2025 period, Keros Therapeutics, Inc.’s shares outstanding has grown by 704.4% (from 2.43 million shares to 19.54 million shares).
- The most recent figure is from Keros Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 4, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: